Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Digestion ; 84(1): 70-7, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21494036

RESUMEN

BACKGROUND/AIMS: The surveillance of subjects at high risk for developing gastric cancer (GC) may represent an effective strategy for reducing specific morbidity and mortality. The aim of this study was to identify GC at its initial phase and to identify precancerous lesions in a group of GC high-risk subjects. METHODS: We enrolled first-degree relatives of patients affected by GC who resided in a GC high-risk area (Tuscany, Central Italy). The study's protocol included the collection of several individual measurements, including a blood sample for the determination of specific biomarkers, an upper digestive tract endoscopy with detailed gastric biopsies and Helicobacter pylori (Hp) treatment followed by a specific check. RESULTS: We enrolled 167 subjects who were members of 128 different familial groups with GC history. We identified 1 case of initial-phase GC, 1 gastric dysplasia type II, 32 intestinal metaplasia, 10 gastric atrophy, and 21 atrophic chronic gastritis. 81 subjects were Hp-positive and underwent eradication therapy. CONCLUSION: This study of a GC high-risk Italian population reveals positive results in terms of population compliance, the identification of specific gastric lesions requiring close follow-up and successful therapy for Hp infection. To define future surveillance strategies, a longer follow-up of these patients is necessary.


Asunto(s)
Helicobacter pylori , Vigilancia de la Población , Lesiones Precancerosas/diagnóstico , Neoplasias Gástricas/diagnóstico , Adulto , Anciano , Biomarcadores/sangre , Biopsia , Endoscopía Gastrointestinal , Femenino , Infecciones por Helicobacter/diagnóstico , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Italia/epidemiología , Masculino , Persona de Mediana Edad , Pepsinógenos/sangre , Factores de Riesgo , Neoplasias Gástricas/microbiología
2.
Eur J Clin Microbiol Infect Dis ; 12(9): 677-82, 1993 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8243483

RESUMEN

On the basis of the MICs of methicillin and oxacillin, 975 clinical isolates of Staphylococcus aureus were categorized as having resistance, borderline susceptibility or full susceptibility to penicillinase-resistant penicillins (PRPs). The borderline phenotype accounted for 122 isolates (12.5%), whereas 562 isolates were fully susceptible and 290 resistant; one remaining isolate had resistance to methicillin and borderline susceptibility to oxacillin. Reductions in the MICs of methicillin and oxacillin in the presence of sulbactam were greater in strains with borderline PRP susceptibility than in fully susceptible or resistant isolates. Over 99% of fully PRP-susceptible strains, 93% with borderline susceptibility and 71% of resistant strains were susceptible to ampicillin/sulbactam. The production of beta-lactamase, assayed in all strains using nitrocefin as substrate, could be detected without prior induction in 729 strains and after induction only in another 156 strains. With only two exceptions, the beta-lactamase negative strains were part of the fully PRP-susceptible group of organisms (88 of 562 isolates). Among the borderline isolates, strong beta-lactamase reactions were encountered with particular frequency, but not in all strains and not exclusively in borderline strains. Although associated with the majority of borderline strains, beta-lactamase hyperproduction thus did not appear to be an essential feature of the borderline phenotype. The results obtained may have implications for laboratory and clinical medicine, also in the light of recent findings suggesting that other mechanisms besides beta-lactamase hyperproduction may account for borderline susceptibility to PRPs.


Asunto(s)
Meticilina/farmacología , Oxacilina/farmacología , Resistencia a las Penicilinas , Penicilinasa/metabolismo , Staphylococcus aureus/efectos de los fármacos , Ampicilina/farmacología , Resistencia a la Ampicilina , Quimioterapia Combinada/farmacología , Humanos , Resistencia a la Meticilina , Pruebas de Sensibilidad Microbiana , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/enzimología , Sulbactam/farmacología , beta-Lactamasas/biosíntesis
5.
Drugs Exp Clin Res ; 11(7): 453-6, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-3836868

RESUMEN

Levels of cefatrizine, a new oral cephalosporin, were determined in blood and in tonsils, paranasal sinus secretions and middle ear exudates from 18 patients with acute infections at these sites. Three and six hours after administration of 500 mg cefatrizine satisfactory levels of the antibiotic were found at all the sites examined. Levels in the tonsils and middle ear were higher than those in blood, while lower levels were recorded in nasal secretions.


Asunto(s)
Cefatrizina/metabolismo , Cefalosporinas/metabolismo , Oído Medio/metabolismo , Tonsila Palatina/metabolismo , Senos Paranasales/metabolismo , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/metabolismo , Cefatrizina/sangre , Cefatrizina/uso terapéutico , Humanos , Cinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA